Abstract
PURPOSE:The global pandemic of COVID-19 has imposed new challenges for the attention of patients with ischemic stroke and large vessel occlusion. Endovascular treatment with mechanical thrombectomy is the therapy of choice for these patients. The recommendations intend to maintain the efficacy, times and safety of the intervention following the new biosafety measures.
METHODOLOGY:A non-systematic review of the literature on endovascular management for ischemic stroke in the pre-COVID-19 period and during the COVID-19 pandemic. The aspects of the intervention, modified in the author's opinion, are presented in the form of narrative recommendations.
RESULTS:Three phases were identified in the endovascular management for cerebral infarction: Pre-intervention, intervention, and post-intervention. The first one includes candidate selection, screening for COVID-19, informed consent, notification-preparation of the team/suite and anesthetic modality. For the other two phases general recommendations were developed. Finally, we identified key points for decision-making in the endovascular management of ischemic stroke.
CONCLUSION:These recommendations pretend to facilitate adaptations of protocols, avoid delays and maintain the safety of endovascular intervention in patients with ischemic stroke with large vessel occlusion candidates for mechanical thrombectomy during COVID-19 pandemic.
References
Saavedra Trujillo CH. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID en 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020;24(3):1-153.
Morens DM, Daszak P, Markel H, Taubenberger JK. Pandemic COVID-19 Joins history's pandemic legion. mBio. 2020;11(3):e812-20. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32471830/
Organización Mundial de la Salud (OMS), Organización Panamericana de la Salud (OPS). La OMS caracteriza a covid-19 como una pandemia. Organización Panamericana de la Salud. 2020. Disponible en: https://www.paho.org/es/noticias/11-3-2020-oms-caracteriza-covid-19-como-pandemia
Takagi H. COVID-19 pandemic and medical publication. Eur J Clin Invest. 2020;50(11):e394-98. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32886801/
Trejo Gabriel, Galán JM. Stroke as a complication and prognostic factor of COVID-19. Neurol Barc Spain. 2020;35(5):318-22. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32493597/
Hess DC, Eldahshan W, Rutkowski E. COVID-19-related stroke. Transl Stroke Res. 2020;11(3):322-5. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32378030/
Hasset C, Gedansky A, Mays M, Uchino K. Acute ischemic stroke and COVID-19. Cleve Clin J Med. 2020;87(12):19-21. Disponible en: https://www.ccjm.org/content/early/2020/11/18/ccjm.87a.ccc042
Requena M, Olivé-Gadea M, Muchada M, García-Tornel Á, Deck M, Juega J, et al. COVID-19 and stroke: incidence and eti-ological description in a high-volume center. J Stroke Cerebro-vasc Dis. 2020 [citado 4 de diciembre del 2020];29(11):105225. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405833/
Ortiz M, Valencia N, Moreno E, Zafra M, Espinel L, Villarreal D, et al. ACV y covid-19: una revisión de los estudios observacionales publicados en época de pandemia. Acta Neurológica Colomb. 2020;36(2):63-74. Disponible en: https://www.acnweb.org/es/acta-neurologica/volumen-36/212-volumen-36-no-2-abril-junio-2020/1871-acv-y-covid-19-una-revision-de-los-estudios-observacionales-publicados-en-epoca-de-pandemia.html
Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol [Internet]. 2020;7(8):e575-82. Disponible en: http://dx.doi.org/10.1016/S2352-3026(20)30216-7
Venketasubramanian N, Hennerici MG. Stroke in COVID-19 and SARS-CoV-1. Cerebrovasc Dis Basel Switz. 2020;49(3):235-6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32454503/
Sierra-Hidalgo F, Muñoz-Rivas N, Torres Rubio P, Chao K, Villanova Martínez M, Arranz García P, et al. Large artery ischemic stroke in severe COVID-19. J Neurol. 2020;267(12):3441-3.
Iyengar K, Mabrouk A, Jain VK, Venkatesan A, Vaishya R. Learning opportunities from COVID-19 and future effects on health care system. Diabetes Metab Syndr. 2020;14(5):943-6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32599533/
Hajdu SD, Pittet V, Puccinelli F, Ben Hassen W, Ben Maacha M, Blanc R, et al. Acute stroke management during the COVID-19 pandemic. Stroke. 2020 [citado 4 de diciembre de 2020];51(8):2593-6. Disponible en: Disponible en: https://www.ahajournals.org/doi/10.1161/STROKEAHA.120.030794
Amaya P, Bayona H, Folleco E, Martínez C, Coral J, Roa Wandurraga LF, et al. Recomendaciones de diagnóstico y tratamiento del ataque cerebrovascular isquémico agudo durante la contingencia por covid-19. Acta Neurol Colomb. 2020;36(2):16-26. Disponible en: https://www.acnweb.org/es/acta-neurologica/volumen-36/211-volumen-36-no-2-suplemento-1-abril-junio-2020/1844-recomendaciones-de-diagnostico-y-tratamiento-del-ataque-cerebrovascular-isquemico-agudo-durante-la-contingencia-por-covid-19.html
Manrique D, Lara O, Giraldo L, Celis J, Restrepo I. Recomendaciones y consideraciones del Comité Vascular de la Asociación Colombiana de Neurología para el manejo del ataque cerebro-vascular isquémico durante la pandemia por covid-19. Acta Neurol Colomb. 2020;36(3):168-84. Disponible en: https://doi.org/10.22379/24224022301
Yang B, Wang T, Chen J, Chen Y, Wang Y, Gao P, et al. Impact of the COVID-19 pandemic on the process and outcome of thrombectomy for acute ischemic stroke. J Neurointerventional Surg. 2020;12(7):664-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32451358/
Sacks D, Baxter B, Campbell BCV, Carpenter JS, Cognard C, Dippel D, et al. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. J Vasc Interv Radiol. 2018;39(6):E61-76. Disponible en: https://doi.org/10.1016/j.jvir.2017.11.026
Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glick-man A, et al. Fair allocation of scarce medical resources in the time of covid-19. N Engl J Med. 2020;382(21):2049-55.
Canelli R, Connor CW, Gonzalez M, Nozari A, Ortega R. Barrier enclosure during endotracheal intubation. N Engl J Med. 2020;382(20):1957-8.
Nguyen TN, Abdalkader M, Jovin TG, Nogueira RG, Jadhav AP, Haussen DC, et al. Mechanical thrombectomy in the era of the COVID-19 pandemic: emergency preparedness for neuroscience teams: a guidance statement from the Society of Vascular and Interventional Neurology. Stroke. 2020;1896-901.
AHA/ASA Stroke council leadership. Temporary emergency guidance to US stroke centers during the coronavirus disease 2019 (COVID-19) pandemic: on behalf of the American Heart Association/American Stroke Association Stroke Council Leadership. Stroke. 2020;51(6):1910-2. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32233972/
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32091533/
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-90.
Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol. 2020;5(3):279-84.
Smith MS, Bonomo J, Knight WA, Prestigiacomo CJ, Richards CT, Ramser E, et al. Endovascular therapy for patients with acute ischemic stroke during the COVID-19 pandemic: a proposed algorithm. Stroke. 2020;1902-9.
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke A. Stroke. 2019;50(12):e344-e418. Disponible en: https://www.ahajour-nals.org/doi/10.1161/STR.0000000000000211
Ospel JM, Goyal M. Endovascular stroke treatment during the COVID-19 pandemic. Nat Rev Neurol. 2020;16(7):351-2. Disponible en: http://dx.doi.org/10.1038/s41582-020-0371-1
Costa ML, Tutton E, Achten J, Grant R, Slowther AM. Informed consent in the context of research involving acute injuries and emergencies. Bone Jt J. 2017;99-B(2):147-50. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28148654/
Qureshi AI, Gilani S, Adil MM, Majidi S, Hassan AE, Miley JT, et al. Pattern of informed consent acquisition in patients undergoing emergent endovascular treatment for acute ischemic stroke. J Vasc Interv Neurol. 2014;7(2):21-5. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25132906/
Abou-Chebl A, Lin R, Shazam M, Jovin T, Levy E, Liebeskind D, et al. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke preliminary results from a retrospective, multicenter study. J Am Heart Assoc. 2010;1175-9.
Jabre P, Combes X, Lapostolle F, Dhaouadi M, Ricard-Hibon A, Vivien B, et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. The Lancet. 2009;374(9686):293-300. Disponible en: http://dx.doi.org/10.1016/S0140-6736(09)60949-1
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.